Substance / Medication

Etoposide phosphate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Woringer-Kolopp disease (localized pagetoid reticulosis): a systematic review.
Osto Muhammad, Afify Omar, Musa Arif et al. · Int J Dermatol · 2023
PMID: 35485962Meta-Analysis
Kaposi Sarcoma of the Larynx: A Systematic Review.
Barron Kendyl, Omiunu Ariel, Celidonio Joseph et al. · Otolaryngol Head Neck Surg · 2023
PMID: 35671149Meta-Analysis
Burden of Kaposi sarcoma according to HIV status: A systematic review and global analysis.
Ibrahim Khalil Ahmadaye, Franceschi Silvia, de Martel Catherine et al. · Int J Cancer · 2022
PMID: 35085400Meta-Analysis
Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma.
Peng Suhua, Yang Kaiying, Xu Zhicheng et al. · J Paediatr Child Health · 2019
PMID: 30604513Meta-Analysis
Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer.
Levitt N C, Propper D J, Madhusudan S et al. · Br J Cancer · 2005
PMID: 15956976TrialFull text (PMC)
Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients.
Reif S, Kingreen D, Kloft C et al. · Cancer Chemother Pharmacol · 2001
PMID: 11561779Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Etoposide phosphate (substance)
SNOMED CT
426891005
UMLS CUI
C0059874

Clinical Data

This intervention maps to 12 entities in the Ltrl knowledge graph.

12
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.